Spring Co-Op 2027, CASGEVY Change Management
Vertex Pharmaceuticals
Summary
The Vertex CASGEVY Change Management Co-Op is a 6-month experiential training program for students currently working towards an undergraduate degree or an advanced degree in Chemical Engineering, Chemistry, or other related fields. The co-op will gain meaningful experience in CMTO, Casgevy Manufacturing functional areas.
Job description
What you will be doing
The CASGEVY Change Management Co-Op will support change control activities within a regulated quality environment, gaining hands-on experience in QMS, lifecycle management, and operational excellence.
Key Responsibilities
- Support the coordination, transmission, and tracking of active change controls across internal teams and contract manufacturing organizations (CMOs).
- Monitor timelines and follow up with stakeholders to help ensure change controls remain on track and are completed on time.
- Contribute to status reporting and metrics related to active change controls.
- Partner with cross-functional stakeholders to develop and create change control templates for use across different functional areas.
- Support the development of AI-enabled content guidance for change control documentation.
- Help create and refine master AI guidelines for drafting change control content in alignment with Vertex SOPs, Quality and compliance expectations, and Change control best practices.
- Work closely with the manager to support an Operational Excellence initiative focused on improving the end-to-end change control process.
- Help develop a lean, scalable solution for change control planning, prioritization, transmission, and tracking from idea through closure.
Qualifications
- Currently pursuing a bachelor’s or master’s degree in Life Sciences, Engineering, Pharmaceutical Sciences, Biotechnology, Quality/Regulatory, Business Operations, or a related discipline.
- Strong organizational skills and attention to detail.
- Ability to manage multiple tasks and follow through on deadlines.
- Strong written and verbal communication skills.
- Interest in quality systems, regulated processes, and operational improvement.
- Ability to work independently while collaborating across functional teams.
- Proficiency in Microsoft Office tools, especially Excel, Word, and PowerPoint.
- Familiarity with process improvement, lean principles, or workflow optimization is a plus.
- Interest in AI tools and content standardization.
- Experience working with structured data, templates, or documentation systems.
- Exposure to QMS, lifecycle management, or change control concepts is a plus.
- Legal authorization to work in the United States, now and in the future.
- You must be enrolled in an advanced degree program if graduating before May 2027.
- You must be available to work full-time, 40 hours per week from January – July 2027.
Requirements
- Currently pursuing a bachelor’s or master’s degree in Life Sciences, Engineering, Pharmaceutical Sciences, Biotechnology, Quality/Regulatory, Business Operations, or a related discipline
- Strong organizational skills and attention to detail
- Ability to manage multiple tasks and follow through on deadlines
- Strong written and verbal communication skills
- Interest in quality systems, regulated processes, and operational improvement
- Ability to work independently while collaborating across functional teams
- Proficiency in Microsoft Office tools, especially Excel, Word, and PowerPoint
- Legal authorization to work in the United States, now and in the future
- You must be enrolled in an advanced degree program if graduating before May 2027
- You must be available to work full-time, 40 hours per week from January – July 2027
Benefits
- Gym access
- Group exercise classes
- Subsidized commuter benefits
- Free breakfast
- Career development opportunities
- Social events
- Medical, Dental & Vision
- Paid time off
- Educational assistance
- Student loan repayment
- Matching charitable donations
- 401(k)
Company overview
Vertex Pharmaceuticals is a global biotechnology company headquartered in Boston, Massachusetts, founded in 1989. The company specializes in discovering, developing, and commercializing transformative medicines for serious diseases, with a primary focus on cystic fibrosis (CF). Vertex has pioneered breakthrough therapies including TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO, which collectively treat approximately 90% of CF patients. Beyond CF, the company has expanded its portfolio to include treatments for sickle cell disease, transfusion-dependent beta thalassemia, acute pain, and has robust clinical pipelines in APOL1-mediated kidney disease, type 1 diabetes, myotonic dystrophy type 1, and alpha-1 antitrypsin deficiency. Vertex employs approximately 6,100 people globally and maintains research facilities in San Diego, California, and Milton Park, Oxfordshire, England. The company is publicly traded on NASDAQ (VRTX) and is recognized as one of the industry's top workplaces, consistently earning accolades for its innovative culture and patient-focused approach to drug development.